Visceral Pain Treatment Market To Surpass US$ 16 Billion By 2027 - Coherent Market Insights

1. VISCERAL PAIN TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Visceral Pain Treatment Market - Overview Global Visceral Pain Treatment Market, by Drug Type (Pain modifiers (Tricyclic Anticonvulsant and Tricyclic Antidepressants), Analgesics (Narcotics and NSAID), and Others), by Indication (Chronic prostatitis, Interstitial cystitis, Crohn’s Disease, and Irritable Bowel Syndrome), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 11,673.8 million in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. Players in the market are focused on research & development and collaborations to develop novel drugs and treatments for different visceral pain. Companies are focusing on licensing agreements to capitalize the market opportunity with synergies. For instance, in February 2020, Novartis AG and the Drugs for Neglected Diseases initiative (DNDi) jointly entered into a licensing agreement in order to co-develop ‘LXE408,’ which is a potential novel visceral leishmaniasis treatment. In March 2018, Arena Pharmaceuticals presented phase I and preclinical data on APD371 for developing pain treatment regarding the Crohn’s disease at the Annual Scientific Summit at American Pain Society. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/visceral- pain-treatment-market-4095 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Visceral Pain Treatment Market - Impact of Coronavirus(Covid-19) Pandemic The COVID-19 outbreak has hugely affected the visceral pain treatment market, as patients with diseases such as Chron’s, IBS, and others are overlooked during the pandemic. The possibility of visceral abdominal pain has main implications in the clinical trials during the COVID-19 pandemic. The visceral infarction must be considered in disparity diagnosis when COVID-19 patients report severe abdominal pain. However, it is challenging for researchers and key players to perform clinical trials during this pandemic crisis. Browse 27 Market Data Tables and 31 Figures spread through 160 Pages and in-depth TOC on Visceral Pain Treatment Market, By Drug Type (Pain modifiers (Tricyclic Anticonvulsant and Tricyclic Antidepressants), Analgesics (Narcotics and NSAID), and Others), By Indication (Chronic prostatitis, Interstitial cystitis, Crohn’s Disease, and Irritable Bowel Syndrome), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Forecast to 2027” Crohn’s disease is one of the most common indications of visceral pain and its incidence in the North America region comes out to be 400 to 600 cases per 100,000 people. According to the CDC (Centers for Disease Control and Prevention), more than 3 million people were diagnosed with IBD (irritable bowel disease) such as Crohn’s or ulcerative colitis in 2015. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4095 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the Global Visceral Pain Treatment Market: The global visceral pain treatment market is expected to exhibit a CAGR of 5.26% during the forecast period (2020-2027), owing to the rising investments by pharmaceutical companies and governments for research and development Among indications, the irritable bowel syndrome segmentis likely to account for the largest revenue share by 2027, owing to the increasing number of irritable bowel syndrome (IBS) cases across the globe. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD) in 2016, around 10-15% of the adult populations across the world are affected by IBS every year. Major players operating in the global visceral pain treatment market include Astellas Pharma Inc., Addex Therapeutics Ltd., Takeda, AstraZeneca, Chromocell Corporation, Allergan, GIcare Pharma Inc., Grunenthal GmbH, Abbvie, Johnson & Johnson, Medestea Research & Production S.p.A., and Neurim Pharmaceuticals Ltd. According to the CDC (Centers for Disease Control and Prevention), more than 3 million people were diagnosed with IBD (irritable bowel disease) such as Crohn’s or ulcerative colitis in 2015. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4095 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved